IRIS
PELAIA, CORRADO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.543
AS - Asia 940
EU - Europa 922
SA - Sud America 166
AF - Africa 23
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.603
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.485
SG - Singapore 567
IT - Italia 479
CN - Cina 209
DE - Germania 159
BR - Brasile 141
FI - Finlandia 66
GB - Regno Unito 64
HK - Hong Kong 47
CA - Canada 39
SE - Svezia 37
IN - India 28
NL - Olanda 25
VN - Vietnam 18
ES - Italia 17
MX - Messico 15
BD - Bangladesh 14
FR - Francia 13
CZ - Repubblica Ceca 10
PL - Polonia 10
AR - Argentina 9
AT - Austria 9
EG - Egitto 9
UA - Ucraina 8
IQ - Iraq 7
PE - Perù 7
ZA - Sudafrica 7
IE - Irlanda 6
MY - Malesia 6
TR - Turchia 6
AU - Australia 5
JP - Giappone 5
RU - Federazione Russa 5
SA - Arabia Saudita 5
EC - Ecuador 4
EE - Estonia 4
CO - Colombia 3
IR - Iran 3
LT - Lituania 3
MA - Marocco 3
PK - Pakistan 3
PT - Portogallo 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
JO - Giordania 2
KR - Corea 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
NP - Nepal 1
PH - Filippine 1
RO - Romania 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.603
Salva come PNG Salva come JPEG
Città #
Singapore 331
Santa Clara 175
Chandler 170
Hefei 159
Dallas 130
Munich 106
Ashburn 68
Milan 68
Princeton 66
Lawrence 65
Turku 47
Chicago 46
Hong Kong 45
Catanzaro 42
Wilmington 41
London 40
Boardman 32
Los Angeles 23
Naples 22
Rome 22
Palermo 21
San Nicola Manfredi 18
Des Moines 16
Helsinki 16
San Francisco 14
São Paulo 14
Bari 13
Florence 13
Brooklyn 12
Ho Chi Minh City 11
Redwood City 11
Troina 11
Olomouc 10
Norwalk 9
Warsaw 9
Atlanta 8
Galbiate 8
Montreal 8
Ottawa 8
Redmond 8
Alessandria 7
Amsterdam 7
Messina 7
New York 7
Seattle 7
Castrovillari 6
Johannesburg 6
Lima 6
Rio de Janeiro 6
The Dalles 6
Boston 5
Cosenza 5
Dublin 5
Hanover 5
Lamezia Terme 5
Mexico City 5
Padova 5
Phoenix 5
Toronto 5
Ankara 4
Assago 4
Aversa 4
Beijing 4
Belo Horizonte 4
Brasília 4
Calgary 4
Columbus 4
Houston 4
Indore 4
Mascalucia 4
Petaling Jaya 4
Providence 4
Quito 4
Raleigh 4
Rende 4
San Jose 4
Sohag 4
Stockholm 4
West Jordan 4
Afragola 3
Baghdad 3
Baltimore 3
Brookline 3
Cerreto Guidi 3
Charlotte 3
Cincinnati 3
Corato 3
Fayetteville 3
Gravina in Puglia 3
Hanoi 3
Manchester 3
Miami 3
New Delhi 3
Paola 3
Pune 3
Riyadh 3
Salvador 3
Soverato Marina 3
Taranto 3
Tokyo 3
Totale 2.189
Salva come PNG Salva come JPEG
Nome #
25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine 81
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 67
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 66
Benralizumab: From the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 58
Evaluation of a New Interface Combining High-Flow Nasal Cannula and CPAP 55
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 55
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 53
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 51
MALDI MS-Based Investigations Targeting SARS-CoV-2 48
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 45
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 45
Association Between Sleep Apnea and Valvular Heart Diseases 45
Recognizing, quantifying and managing patient-ventilator asynchrony in invasive and noninvasive ventilation. 44
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 44
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 43
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 42
Comparisons of two diaphragm ultrasound-teaching programs: a multicenter randomized controlled educational study. 42
Biologics in severe asthma 42
Fluid Challenge During Anesthesia: A Systematic Review and Meta-analysis. 40
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 40
Nasal polyposis: Insights in epithelial-mesenchymal transition and differentiation of polyp mesenchymal stem cells 40
Current Practice of High Flow through Nasal Cannula in Exacerbated COPD Patients 40
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 39
Nurse led protocols for control of glycaemia in critically ill patients: A systematic review 37
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 37
Patient-ventilator asynchrony in adult critically ill patients 37
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 37
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 37
Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade 36
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 36
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 36
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 36
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 36
Assessment of cephalometric parameters and correlation with the severity of the obstructive sleep apnea syndrome 35
Device for Performing Spirometry in Total Laryngectomized Patients 34
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 34
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 34
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 33
Tezepelumab: A potential new biological therapy for severe refractory asthma 33
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 33
Asthma control during COVID-19 lockdown in patients with severe asthma under biological drug treatment 33
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 32
Benefits of secretion clearance with high frequency percussive ventilation in tracheostomized critically ill patients: a pilot study 31
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 31
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 31
What is the Role of Sex-Related Differences in the Effectiveness and Safety of Biological Drugs used in Patients' Severe Asthma? 30
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 30
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 30
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 29
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 29
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 28
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 27
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 27
Effects of continuous positive airway pressure on comprehensive geriatric assessment and cognitive function in elderly patients with obstructive sleep apnea syndrome 27
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 27
Intrinsic laryngeal lipoma treated with transoral Co2 laser microsurgery: An unusual case report 27
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 26
Emerging biological treatments for asthma 25
Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma 25
Primary mucosal melanoma presenting with a unilateral nasal obstruction of the left inferior turbinate 25
Complications during Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19 and Non-COVID-19 Patients with Acute Respiratory Distress Syndrome 24
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 24
MALDI MS-Based Investigations for SARS-CoV-2 Detection 24
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic 23
Type 2 severe asthma: pathophysiology and treatment with biologics 23
Novel Biological Therapies for Severe Asthma Endotypes 23
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 23
Severe Eosinophilic Asthma: from the Pathogenic role of Interleukin-5 to the Therapeutic Action of Mepolizumab. 23
Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study. 23
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives 23
Role of p38 mitogen-activated protein kinase in asthma and COPD: Pathogenic aspects and potential targeted therapies 23
Oxygenation strategies during flexible bronchoscopy: a review of the literature 23
Intraoperative protective ventilation in patients undergoing major neurosurgical interventions: a randomized clinical trial 23
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 22
Cost-Sensitive Models to Predict Risk of Cardiovascular Events in Patients with Chronic Heart Failure 22
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 22
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 22
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 21
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 20
Association between non-dipping blood pressure pattern and different glucometabolic profile during oral glucose tolerance test 20
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 20
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 19
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 19
Do Comorbidities Influence the Response to Biologics in Severe Asthma? 19
New potential biomarkers for early chronic kidney disease diagnosis in patients with different glucose tolerance status 19
Phenotyping severe asthma: a rationale for biologic therapy 19
Clinical remission in severe asthma: lights and shadows on an ambitious goal 18
Influence of allergic status and nasal polyposis on long-term Benralizumab response in eosinophilic severe asthma 18
TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD 18
Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients 18
Mechanical ventilation in brain injured patients: seeing the forest for the trees 18
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: results of a single-centre observational study 18
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis 18
Monoclonal antibodies targeting alarmins: A new perspective for biological therapies of severe asthma 18
Switch from omalizumab to benralizumab in allergic patients with severe eosinophilic asthma: A real-life experience from Southern Italy 18
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma 18
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 17
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 17
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 17
Novel Biological Therapies for Severe Asthma Endotypes 17
Totale 3.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021138 0 0 5 10 22 13 3 9 57 10 5 4
2021/2022233 5 5 29 31 7 8 22 40 29 22 34 1
2022/2023600 137 32 40 23 60 52 26 51 80 27 52 20
2023/2024380 67 45 32 27 12 75 6 17 6 25 24 44
2024/20251.637 166 18 26 32 191 215 109 49 165 53 257 356
2025/2026776 237 492 47 0 0 0 0 0 0 0 0 0
Totale 3.827